Testing an 8-Week Dyadic Co-learning Program for Patients with Prostate Cancer and Their Spouses to Improve Well-Being and Resilience

What this Trial Is About

Researchers are evaluating a Dyadic Co-learning Intervention designed for patients with prostate cancer and their spouses to help them better cope with the challenges of cancer. This study aims to improve physical symptoms, emotional well-being, and resilience through shared learning and support. The trial uses a randomized controlled design to compare routine care alone with routine care plus the new co-learning program. Participants will be randomly assigned to either a control group receiving routine care or an experimental group receiving routine care plus an 8-week Dyadic Co-learning Intervention. This intervention includes a co-learning handbook, a mobile app, and professional support. The program encourages patients and their spouses to learn and support each other together over the course of 8 weeks. Participants will complete questionnaires at the start of the study, and again at 10 and 16 weeks after baseline to measure outcomes such as family resilience, physical symptoms, fatigue, loneliness, subjective well-being, and satisfaction with the intervention. The study monitors both patients and spouses to assess the interventions effects on their health and well-being over time.

Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses